STRS Ohio’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

STRS Ohio’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-253	Closed	-$20K	–	2296
2020 Q1	$20K	Hold	253	–	–	﹤0.01%	1909
2019 Q4	$23K	Hold	253	–	–	﹤0.01%	1964
2019 Q3	$19K	Hold	253	–	–	﹤0.01%	1983
2019 Q2	$25K	Buy	+253	New	+$19.6K	﹤0.01%	2012

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

STRS Ohio's EVFM Position: Q2 2020 in Review

STRS Ohio sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2020, closing a stake of 253 shares — an estimated $20K sold.

STRS Ohio first reported a position in EVFM in Q2 2019 and held it in 4 quarters. The position peaked at $25K in Q2 2019. 122 funds tracked by Wall St. Rank hold EVFM as of Q2 2020.

STRS Ohio reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
STRS Ohio sold 253 Evofem Biosciences, Inc. Common Stock shares in Q2 2020, an estimated $20K.
STRS Ohio first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
STRS Ohio's Evofem Biosciences, Inc. Common Stock position peaked at $25K in Q2 2019.
122 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2020.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.